John Libbey Eurotext

European Journal of Dermatology


Cetuximab-induced epidermolysis revealed by multiple erosions Volume 28, numéro 4, July-August 2018


  • Figure 1
1 Department of Dermatology,
2 Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510 Japan

Cetuximab, an inhibitor of epidermal growth factor receptor (EGFR), can induce a variety of adverse skin reactions, including papulopustular rash, paronychia and fissures, xerosis, and pruritus [1-3]. However, cases of cetuximab-induced epidermal necrosis, including toxic epidermal necrolysis, are extremely rare [4, 5]. Furthermore, detailed analysis of this adverse skin reaction has not been performed to date. Here, we present a rare case of cetuximab-induced multiple erosions as an adverse skin [...]